Short-term effects of pamidronate on bone turnover: can bone markers be considered predictive of the analgesic response?


Few data are available on the ability of bone markers to predict the symptomatic response to bisphosphonate therapy in patients with painful bone metastases. We evaluated the levels of bone markers in patients with bone metastases receiving pamidronate and determined the corresponding analgesic response. Forty-two patients were administered two two-week… (More)

7 Figures and Tables


  • Presentations referencing similar topics